Changes in cancer incidence and mortality in Australia over the period 1996-2015
- PMID: 33303018
- PMCID: PMC7726606
- DOI: 10.1186/s13104-020-05395-6
Changes in cancer incidence and mortality in Australia over the period 1996-2015
Abstract
Objective: A previous Australian study compared the observed numbers of cancer cases and deaths in 2007 with the expected numbers based on 1987 rates. This study examines the impact of cancer rate changes over the 20-year period 1996-2015, for people aged under 75 years.
Results: The overall age-standardised cancer incidence rate increased from 350.7 in 1995 to 364.4 per 100,000 in 2015. Over the period 1996-2015, there were 29,226 (2.0%) more cases (males: 5940, 0.7%; females: 23,286, 3.7%) than expected numbers based on 1995 rates. Smaller numbers of cases were observed compared to those expected for cancers of the lung for males and colorectum, and cancers with unknown primary. Larger numbers of cases were observed compared to those expected for cancers of the prostate, thyroid and female breast. The overall age-standardised cancer mortality rate decreased from 125.6 in 1995 to 84.3 per 100,000 in 2015. During 1996 to 2015 there were 106,903 (- 20.6%) fewer cancer deaths (males: - 69,007, - 22.6%; females: - 37,896, - 17.9%) than expected based on the 1995 mortality rates. Smaller numbers of deaths were observed compared to those expected for cancers of the lung, colorectum and female breast, and more cancer deaths were observed for liver cancer.
Keywords: Australia; Cancer control; Cancer incidence; Cancer mortality.
Conflict of interest statement
KC is co-PI of an unrelated investigator-initiated trial of cytology and primary HPV screening in Australia ('Compass’), which is conducted and funded by the Victorian Cytology Service (VCS), a government-funded health promotion charity. The VCS has received equipment and a funding contribution for the Compass trial from Roche Molecular Systems and Ventana Inc USA. However, neither KC nor her institution (Cancer Council NSW) receives direct funding from industry for this trial or any other project.
Figures

Similar articles
-
Cancer incidence and mortality in people aged less than 75 years: changes in Australia over the period 1987-2007.Cancer Epidemiol. 2013 Dec;37(6):780-7. doi: 10.1016/j.canep.2013.09.010. Epub 2013 Oct 30. Cancer Epidemiol. 2013. PMID: 24183782
-
Comparison of cancer mortality and incidence in New Zealand and Australia.N Z Med J. 2002 May 10;115(1153):205-8. N Z Med J. 2002. PMID: 12064704
-
Italian cancer figures--Report 2015: The burden of rare cancers in Italy.Epidemiol Prev. 2016 Jan-Feb;40(1 Suppl 2):1-120. doi: 10.19191/EP16.1S2.P001.035. Epidemiol Prev. 2016. PMID: 26951748
-
[SENTIERI - Epidemiological Study of Residents in National Priority Contaminated Sites. Sixth Report].Epidemiol Prev. 2023 Jan-Apr;47(1-2 Suppl 1):1-286. doi: 10.19191/EP23.1-2-S1.003. Epidemiol Prev. 2023. PMID: 36825373 Italian.
-
Cancer in Australia: Actual incidence data from 1982 to 2013 and mortality data from 1982 to 2014 with projections to 2017.Asia Pac J Clin Oncol. 2018 Feb;14(1):5-15. doi: 10.1111/ajco.12761. Epub 2017 Sep 20. Asia Pac J Clin Oncol. 2018. PMID: 28929586 Review.
Cited by
-
Trends and projections of cause-specific premature mortality in Australia to 2044: a statistical modelling study.Lancet Reg Health West Pac. 2024 Jan 5;43:100987. doi: 10.1016/j.lanwpc.2023.100987. eCollection 2024 Feb. Lancet Reg Health West Pac. 2024. PMID: 38456088 Free PMC article.
-
Identifying cancer driver genes in individual tumours.Comput Struct Biotechnol J. 2023 Oct 13;21:5028-5038. doi: 10.1016/j.csbj.2023.10.019. eCollection 2023. Comput Struct Biotechnol J. 2023. PMID: 37867967 Free PMC article. Review.
-
Projections of smoking-related cancer mortality in Australia to 2044.J Epidemiol Community Health. 2022 Jun 24;76(9):792-9. doi: 10.1136/jech-2021-218252. Online ahead of print. J Epidemiol Community Health. 2022. PMID: 35750482 Free PMC article.
-
Did the COVID-19 pandemic delay treatment for localized breast cancer patients? A multicenter study.PLoS One. 2024 May 31;19(5):e0304556. doi: 10.1371/journal.pone.0304556. eCollection 2024. PLoS One. 2024. PMID: 38820299 Free PMC article.
-
Cancer incidence and mortality in Australia from 2020 to 2044 and an exploratory analysis of the potential effect of treatment delays during the COVID-19 pandemic: a statistical modelling study.Lancet Public Health. 2022 Jun;7(6):e537-e548. doi: 10.1016/S2468-2667(22)00090-1. Lancet Public Health. 2022. PMID: 35660215 Free PMC article.
References
-
- Global Cancer Observatory: cancer today. Lyon, France: International Agency for Research on Cancer. Available from: https://gco.iarc.fr/today. Accessed 3 June 2019.
-
- Sitas F, Gibberd A, Kahn C, Weber MF, Chiew M, Supramaniam R, Velentzis L, Nickson C, Smith DP, O’Connell D, et al. Cancer incidence and mortality in people aged less than 75 years: changes in Australia over the period 1987–2007. Cancer Epidemiol. 2013;37(6):780–787. doi: 10.1016/j.canep.2013.09.010. - DOI - PubMed
-
- Luo Q, Steinberg J, O'Connell DL, Yu XQ, Caruana M, Wade S, Pesola F, Grogan PB, Dessaix A, Freeman B, et al. Lung cancer mortality in Australia in the twenty-first century: How many lives can be saved with effective tobacco control? Lung Cancer. 2019;130:208–215. doi: 10.1016/j.lungcan.2019.02.028. - DOI - PubMed
-
- Australian Institute of Health Welfare. National cancer screening programs participation data. 2020. Cat. No: CAN 114, last updated 29 Jan 2019. Available from: https://www.aihw.gov.au/reports/cancer-screening/national-cancer-screeni.... Last accessed 30 Jan 2019.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical